Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)

Nina Hasiwa, Mardas Daneshian, Peter Bruegger, Stefan Fennrich, Astrid Hochadel, Sebastian Hoffmann, Felix E. Rivera-Mariani, Christoph Rockel, Stefanie Schindler, Ingo Spreitzer, Sandra Stoppelkamp, Kranthi Vysyaraju, Thomas Hartung

Research output: Contribution to journalComment/debatepeer-review

Abstract

Regarding this t4 report, which appeared in ALTEX (2013), 30(2), as co-author Thomas Hartung would like to acknowledge that the respective patents referred to, which he holds as the co-inventor of the whole blood pyrogen test, were at the time of the article licensed to Biotest Pharmaceuticals, Germany, and he received royalties from sales of this test. The license and associated royalty payment obligations were in the meantime transferred to Merck-Millipore, France.

Original languageEnglish (US)
Pages (from-to)499
Number of pages1
JournalALTEX
Volume31
Issue number4
DOIs
StatePublished - 2014

ASJC Scopus subject areas

  • Pharmacology
  • Medical Laboratory Technology

Fingerprint Dive into the research topics of 'Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)'. Together they form a unique fingerprint.

Cite this